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Attenuation of HIF-1 DNA-binding activity limits
hypoxia-inducible endothelin-1 expression
Abstract
Hypoxia-inducible factors (HIFs) locate to HIF-binding sites (HBSs) within the hypoxia-response
elements (HREs) of oxygen-regulated genes. Whereas HIF-1alpha is expressed ubiquitously,
HIF-2alpha is found primarily in the endothelium, similar to endothelin-1 (ET-1) and fms-like tyrosine
kinase 1 (Flt-1), the expression of which is controlled by HREs. We identified an unique sequence
alteration in both ET-1 and Flt-1 HBSs not found in other HIF-1 target genes, implying that these HBSs
might cause binding of HIF-2 rather than HIF-1. However, electrophoretic mobility shift assays showed
HIF-1 and HIF-2 DNA complex formation with the unique ET-1 HBS to be about equal. Both
DNA-binding and hypoxic activation of reporter genes using the ET-1 HBS was decreased compared
with transferrin and erythropoietin HBSs. The Flt-1 HBS was non-functional when assayed in isolation,
suggesting that additional factors are required for hypoxic up-regulation via the reported Flt-1 HRE.
Interestingly, HIF-1 activity could be restored fully by point-mutating the ET-1 (but not the Flt-1) HBS,
suggesting that the wild-type ET-1 HBS attenuated the full hypoxic response known from other
oxygen-regulated genes. Such a mechanism might serve to limit the expression of this potent
vasoconstrictor in hypoxia.
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Abstract. Hypoxia-inducible factors (HIFs) locate to HIF-binding sites (HBSs) within the hypoxia-response
elements (HREs) of oxygen-regulated genes. Whereas HIF-1  is expressed ubiquitously, HIF-2  is found
primarily in the endothelium, similar to endothelin-1 (ET-1) and fms-like tyrosine kinase 1 (Flt-1), the
expression of which is controlled by HREs. We identified an unique sequence alteration in both ET-1 and
Flt-1 HBSs not found in other HIF-1 target genes, implying that these HBSs might cause binding of HIF-2
rather than HIF-1. However, electrophoretic mobility shift assays showed HIF-1 and HIF-2 DNA complex
formation with the unique ET-1 HBS to be about equal. Both DNA-binding and hypoxic activation of
reporter genes using the ET-1 HBS was decreased compared with transferrin and erythropoietin HBSs. The
Flt-1 HBS was non-functional when assayed in isolation, suggesting that additional factors are required for
hypoxic up-regulation via the reported Flt-1 HRE. Interestingly, HIF-1 activity could be restored fully by
point-mutating the ET-1 (but not the Flt-1) HBS, suggesting that the wild-type ET-1 HBS attenuated the full
hypoxic response known from other oxygen-regulated genes. Such a mechanism might serve to limit the
expression of this potent vasoconstrictor in hypoxia.
Keywords. Angiogenesis - Endothelin - Hypoxia - Vascular endothelial growth factor receptor -
Vasoconstriction
Introduction
Limited O2 supply (hypoxia) can alter the expression pattern of a specific set of genes involved in
mammalian O2 homeostasis, such as those encoding erythropoietin (EPO), transferrin or vascular
endothelial growth factor (VEGF). Analysis of the 3 -flanking region of the EPO gene revealed the
presence of an hypoxia-response element (HRE) binding the transcription factor hypoxia-inducible factor-1
(HIF-1, reviewed in [57, 72]). HIF-1 is a ubiquitously expressed 1 1 heterodimer that specifically
recognizes the HIF-binding site (HBS) within a HRE [70]. Under normoxic conditions, the
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von-Hippel-Lindau tumour suppressor protein (pVHL) targets the HIF -subunits for rapid ubiquitination
and proteasomal degradation [44 -subunits, a
protein modification that is directly dependent on O2 [28, 30]. HIF-1 , previously identified [24] as the aryl
hydrocarbon receptor nuclear translocator (ARNT), is required to form a functional DNA-binding complex,
but not for hypoxic HIF-1  induction and nuclear translocation [6, 31]. Knock-out mouse models have
demonstrated the major role of HIF-1 in O2
O2-regulated genes [5, 29, 56].
Recently, HIF-2  [10, 16, 25, 65] and HIF-3  [22] have been identified and show a more restricted
expression pattern. HIF-2  is expressed mainly in endothelial cells [65] and in the organ of Zuckerkandl,
the major site of fetal catecholamine production [66]. Other reports have also shown HIF-2  mRNA
expression in smooth muscle cells of the uterus, neurons and brown adipose tissue [16] and in stromal cells
of haemangioblastomas [17]. HIF-2  plays a major role in the regulation of fetal catecholamine production
and in vascular remodelling during developmental vasculogenesis [53, 66]. In contrast to the in vivo
expression pattern, HIF-2  expression is widespread in in vitro cultured cells [75] and functional
comparison between HIF-1  and HIF-2  has revealed many similarities [11, 26, 44, 51, 75]. Expression of
all three HIF -subunits has also been observed in the liver [33] although the detailed expression pattern
and functional role of HIF-3  still remain to be elucidated.
The majority of the reported HIF-1-regulated genes are involved in O2 homeostasis at the cellular, local and
systemic levels. At the local level, for example, HIF-1 activates VEGF, which in turn induces angiogenesis,
2 supply. VEGF (VEGF-A) and its two
receptors (VEGFR) fms-like tyrosine kinase (Flt-1, VEGFR-1) and fetal liver kinase-1/kinase insert
domain-containing receptor (Flk-1/KDR, VEGFR-2) are important regulators of physiological and
pathological (e.g. in solid tumour formation) blood vessel growth [13]. Endothelin-1 (ET-1) modulates local
blood circulation by regulating vascular tone and blood pressure. ET-1, a 21-amino acid peptide synthesized
and secreted by vascular endothelial cells, is among the most potent endogenous vasoconstrictors known
[47]. Hypoxia is an important inducer of ET-1 [34] and might also be responsible for increased ET-1
production during myocardial ischaemia [71].
It has been suggested that both Flt-1 [19] and ET-1 [27] are up-regulated transcriptionally by HIF-1 under
hypoxic conditions. Interestingly, sequence comparison of the reported putative HBSs within both Flt-1 and
ET-1 HREs, revealed a sequence distinct from the tentative HIF-1 consensus sequence known from many
other hypoxia-regulated HIF-1 target genes. In the present study we thus addressed the question of whether
this unique HBS represents a consensus recognition sequence specific for HIF-2.
Materials and Methods
Cell culture
The human HeLa cervical carcinoma and Hep3B and HepG2 hepatoma cell lines were obtained from
American Type Culture Collection (ATCC numbers CCL-2, HB-8064 and HB-8065, respectively). The
mouse L929 fibroblast (ATCC CCL-1), the Hepa1 (also termed Hepa1c1c7) hepatoma and the human
endothelial EAhy926 cell lines were kindly provided by V. O'Donnall (Bern, Switzerland), L. Poellinger
(Stockholm, Sweden) and H. Joch (Zürich, Switzerland), respectively. Cell culture and hypoxic exposure
was performed as described previously [4]. Bovine and porcine aortae were obtained from a local abattoir
(Zürich, Switzerland). Primary bovine aortic endothelial cells (BAECs) and porcine aortic endothelial cells
(PAECs) were detached by adding 0.125% (w/v) collagenase (Sigma) for 15 min and harvested by gentle
scraping. Collected endothelial cells (ECs) were transferred to gelatine-coated Petri dishes and cultured as
above.
RNA blot analysis
Total cellular RNA was prepared and RNA blots analysed as described previously [55]. Hybridization
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probes were kindly provided by the following persons: mouse HIF-2 , L. Poellinger; mouse HIF-3 , C.A.
Bradfield (Madison, Wis., USA); human ARNT, Y. Fujii-Kuriyama (Tohoku, Japan); human glucose
transporter-1 (Glut-1), B. Thorens (Lausanne, Switzerland); mouse Flt-1, H.H. Marti (Bad Nauheim,
Germany); human ET-1, W. Moritz (Zürich, Switzerland). The mouse HIF-1 , mouse VEGF and human
ribosomal protein L28 probes were obtained as reported previously [55]. Hybridization probes were labelled
with 32P-dATP to a specific activity of 1 109
inter-species similarity between probe and target mRNA was always higher than 80%. This degree of
similarity did not result in observable differences in signal intensities under the chosen hybridization and
wash stringencies.
Protein extraction and immunoblot analysis
Nuclear extracts were prepared and immunoblots analysed as described previously [35, 74]. Membranes
were stained with Ponceau S (Sigma) to confirm equal protein loading and transfer. HIF-1  and HIF-2
were detected using a mouse monoclonal IgG1 antibody (mgc3) [4] and polyclonal rabbit antibodies kindly
provided by I. Flamme (Wuppertal, Germany), respectively. Horseradish peroxidase-coupled secondary goat
anti-mouse antibodies (Pierce) and luminol (Sigma) chemiluminescent substrate were used for detection.
Electrophoretic mobility shift assay (EMSA)
The DNA sequences of the oligonucleotides probes used for EMSA are shown in Table 1C. The probes
were end-labelled with 32P-ATP to a specific activity of 5 106 cpm/pmol using T4 polynucleotide
kinase (MBI Fermentas). EMSAs and competition experiments were performed as described previously
[35]. In vitro transcription and translation of HIF-1 , HIF-2  and ARNT was performed using the
TNT-coupled transcription-translation system (Promega) primed with the plasmids
pBluescript/HIF-1 3.2-3T7 [70], pmHLF [10] or pBSArntKS+ [24], respectively, as described previously
[20]. For supershift analysis, 1 µl anti-HIF-1  (mgc3) [4] or anti-HIF-2  (190b, kindly provided by P.
Ratcliffe, Oxford, UK) [63, 75] antibody was added to the completed binding reaction.
Reporter gene assays
Luciferase reporter gene constructs were obtained by inserting the oligonucleotides ET-1wt, ET-1T, Flt-1wt
and Flt-1T into the blunted BamHI site 3
(Promega). Copy number and orientation of the oligonucleotides were determined by DNA sequencing
using RVprimer4 (Promega). The construction of pGLHIF1.3 has been reported previously [35]. Transient
transfections and determination of luciferase activity were carried out as described previously [55].
Results
Widespread expression of HIF-1  and HIF-2  in cultured cells in vitro
To determine the relative expression of HIF-1 , HIF-2  and HIF-3  mRNAs in various cell lines, human
HeLa, Hep3B and HepG2, mouse L929 and Hepa1 and BAECs and PAECs were cultured under normoxic
or hypoxic conditions for 4 h and mRNA levels determined by RNA blot analysis (Fig. 1A). HIF-1
mRNA expression was detected in all cell lines tested; the highest HIF-1  levels were observed in the ECs.
HIF-2  was expressed strongly in PAECs and the human cell lines, but was hardly detectable in BAECs
and the mouse cell lines, despite the use of a mouse HIF-2  hybridization probe. HIF-3  mRNA was not
detectable in any of the cell lines tested and its expression pattern awaits further clarification. As expected,
ARNT mRNA was expressed ubiquitously. Following normalization with respect to the signal obtained by
hybridization with the ribosomal protein L28 cDNA probe, constitutive expression of HIF-1  and HIF-2
mRNA was found in all of the cell lines tested, except the human hepatoma cell lines, which showed
hypoxic induction of HIF-2  mRNA. Expression of the HIF-1 target genes Glut-1 and VEGF increased
strongly upon hypoxic stimulation of all cell lines, with the exception of BAECs. mRNA expression levels
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of ET-1 and Flt-1 were too low to be detected in this blot. 
Fig. 1. Hypoxia-induced factor (HIF)-1  and HIF-2  expression in endothelial cells. A Cells were
exposed for 4 h to normoxic (-; 20% O2) or hypoxic (+; 1% O2) conditions. Total RNA was isolated,
blotted and subsequently hybridized to the indicated cDNA probes. Hybridization to the ribosomal protein
L28 served as control for equal loading and blotting efficiency. The data shown were originally derived
from the same Northern blot. B Immunoblot analysis of HIF-1  in nuclear extracts derived from HeLa and
EAhy926 cell lines as well as primary bovine (BAECs) and porcine (PAECs) aortic endothelial cells
exposed for 4 h to normoxic or hypoxic conditions. C Immunoblot analysis of HIF-2  in nuclear extracts
derived from HeLa and EAhy926 cells exposed for 4 h to normoxic or hypoxic conditions (ARNT aryl
hydrocarbon receptor nuclear translocator, Glut-1 glucose transporter-1, VEGF vascular endothelial growth
factor)
Protein levels of HIF-1  and HIF-2  were determined by immunoblot analysis of nuclear extracts from
cells cultured under normoxic or hypoxic conditions (Fig. 1B and C, respectively). Hypoxia strongly
induced HIF-1  in HeLa and EAhy926 cells and in both primary ECs. HIF-2 , previously reported to be
expressed in primary ECs [23, 42], was also detected in hypoxic HeLa cells and, to a lesser extent, in
EAhy926 cells, indicating that the expression of HIF-2
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cell culture conditions. These results confirmed the widespread expression of HIF-1  and HIF-2  [75] and
raised the question of whether, and if so, how, these two HIFs can distinguish between their specific target
genes.
Unique sequence composition of the putative HBSs located in the two endothelial
cell-specific genes ET-1 and Flt-1
Table 1A summarizes the HBSs described from all genes identified to date as direct targets of HIF-1
function. The HIF-1 consensus DNA binding site contains CGTG as the conserved core sequence, usually
preceded by an adenosine and followed by a cytosine residue. Comparison with the reported ET-1 and Flt-1
HBSs (Table 1B) revealed an adenosine residue 5  to the core sequence, which occurred otherwise very
rarely at this position (1 out of 44). It is an astonishing coincidence that this sequence alteration was found
in precisely the only two hypoxia-inducible genes that are expressed preferentially in endothelium, but are
completely unrelated otherwise. We therefore hypothesized that ET-1 and Flt-1 are hypoxically up-regulated
by HIF-2 rather than HIF-1, not because of predominant HIF-2  expression in ECs (see above), but due to
preferential binding of HIF-2 to this unusual HBS.
Table 1. Sequence comparison of hypoxia-inducible factor (HIF) binding sites (HBSs). A Compilation of
HIF target genes and their HBSs. Capital letters bold
face core motif. Studies showing direct DNA binding (DB) and transactivation (TA) of reporter genes are
indicated by a + sign. Transactivation-inactive HBSs, despite proven HIF-binding, are indicated by a - sign.
B Putative HIF DNA-binding site of the two endothelium-specific genes endothelin-1 (ET-1) and fms-like
tyrosine kinase-1 (flt-1). C Oligonucleotide sequences containing either wild-type [ET-1wt, Flt-1wt and
erythropoietin (EPO)] or mutated (ET-1T and Flt-1T) HBSs (FS flanking sequence, IVS intervening
sequence, UT untranslated, ND not determined, VEGF vascular endothelial growth factor, iNOS inducible
NO synthase, IGFBP-1 insulin-like growth factor binding protein, PAI-1 plasminogen activator inhibitor-1,
Tf transferrin, TfR transferrin receptor, PFK-L phosphofructokinase-L, GAPDH glyceraldehyde-3-phosphate
dehydrogenase, PGK-1 phosphoglycerate kinase-1, LDH-A lactate dehydrogenase-A, Glut-1 glucose
transporter-1, CA-9 carboanhydrase-9, Nip-3 nineteen-kD interacting protein, VEGFR1 VEGF receptor-1, h
human, m mouse, r rat, ch Chinese hamster)
HIF binding site Location Hypoxia-induciblegene Species DB TA References
A
tgca TACGTGGGCT ccaa 5 -FS
-978/-961 VEGF h + + [18, 40]
tgca TACGTGGGCT tcca 5 -FS
+61/+78 VEGF r + + [39]
tgac TACGTGCTGC ctag 5 -FS
-229/-212 iNOS m + + [45, 52]
agcg GACGTGCTGG cgtg 5 -FS
+322/+339 Haem oxygenase 1 m + + [38]
agag GACGTGCCAC gcca 5 -FS
+350/+333 Haem oxygenase 1 m + + [38]
aggc GACGTGCTGC cggg 5 -FS
-169/-151 1B
-Adrenoreceptor r + + [9]
caac TACGTGCTCT ggtt IVS1
+669/+652 IGFBP-1 h ND + [64]
gcag GACGTGCTCT ggga IVS1
+710/+727 IGFBP-1 h ND + [64]
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tgcc CACGTGCTGG caag IVS1
+928/+911 IGFBP-1 h ND + [64]
ggga CACGTGTGTG tacg 5 -FS
-156/-173 PAI-1 r + + [32]
ggca AACGTGTTCG aact 5 -FS
-1106/-1089 Adrenomedullin m + + [7, 49]
gaaa TACGTGCGCT ttgt 5 -FS
-201/-184 Tf h + + [55]
tgtg TACGTGCAGG aaag 5 -FS
-185/-168 Tf h + + [55]
agcg TACGTGCCTC agga 5 -FS -93/-76 TfR h + + [41, 61]
gccc TACGTGCTGT ctca 3 -FS
+3065/+3082 EPO h + + [69]
gccc TACGTGCTGC ctcg 3 -FS
+359/+376 EPO m + + [14]
tgca GACGTGCGTG tggg 5 -FS
-163/-180 EPO h + + [58]
ggcg TACGTGCTGC ag IVS1
+346/+361 PFK-L m + + [58]
ctcg GACGTGACTC ggac 5 -FS
-184/-201 Aldolase A h + + [59]
tctt CACGTGCGGG gacc IVS4
+124/+141 Aldolase A h + - [58]
gagc TACGTGCGCC cgta 5 -FS
-115/-132 GAPDH h + + [21]
gccg GACGTGACAA acgg 5 -FS
-206/-189 PGK-1 h + ND [59]
gtga GACGTGCGGC ttcc 5 -FS
-173/-190 PGK-1 h + + [58]
tgcc GACGTGCGCT ccgg 5 -UT
+30/+13 PGK-1 h + ND [58]
tcgc GTCGTGCAGG acgt 5 -FS
-226/-209 PGK-1 m + ND [50]
gcag GACGTGACAA atgg 5 -FS
-217/-200 PGK-1 m + + [14]
gtga GACGTGCTAC ttcc 5 -FS
-184/-201 PGK-1 m + ND [50]
gggc CACGTGCGCC gcct 5 -FS
-590/-607 Enolase 1 h + - [58]
gccg GACGTGGGGC ccca 5 -FS
-413/-396 Enolase 1 h + - [59]
tgag TGCGTGCGGG actc 5 -FS
-386/-369 Enolase 1 h + + [59]
ggag TACGTGACGG agcc 5 -FS
-368/-351 Enolase 1 h + + [59]
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ccta CACGTGGGTT cccg 5 -FS -89/-72 LDH-A m + + [15]
agcg GACGTGCGGG aacc 5 -FS -62/-79 LDH-A m + + [15]
caca GGCGTGCCGT ctga 5 -FS
+273/+290 Glut-1 m + + [8, 50]
ctga TGCGTGTCAG acgg 5 -FS
+300/+283 Glut-1 m + + [50]
agag TACGTGCTA 5 -FS
-101/-113
Retrotransposon
VL30 r + + [12]
tgtg CGCGTGGTGC cata 5 -FS
-1197/-1184 p35srj h + + [2]
acgg GACGTGCAGC tacg 5 -FS
-1180/-1167 p35srj h + + [2]
cagc TACGTGCCCA cctc 5 -FS
-1170/-1157 p35srj h + + [2]
tctg TACGTGACCA cact 5 -FS
-3639/-3544 Ceruloplasmin h + + [48]
tcgc TACGTGCGCT cagt 5 -FS -75/-92 Prolyl 4-hydroxylase  (I) r + + [62]
gctg TACGTGCATT ggaa 5 -FS +2/-16 CA-9 h ND + [76]
gccg CACGTGCCGC acgc 5 -FS
-191/-174
Nip3 proapoptotic
protein ch ND + [3]
ccgc CGCGTGCGTC ctgc 5 -FS
-164/-147
Nip3 proapoptotic
protein ch ND + [3]
  T19 A38 CGTG C31 G16 G19 C16
  G16 G5 G5 T13 C12 G12
  C8 T1 A5 C11 A6 T11
  A1 T3 A4 T7 A4
B
aggc AACGTGCAGC cgga 5 -FS
-114/-131 ET-1 h/(r) + + [27]
gaac AACGTGGAAT tagt 5 -FS
+1408/+1425 Flt-1 (VEGFR1) m/(h) ND + [19]
C
aggc AACGTGCAGC cgga ET-1wt
aggc TACGTGCAGC cgga ET-1Ta
gaac AACGTGGAAT tagt Flt-1wt
gaac TACGTGGAAT tagt Flt-1Ta
gccc TACGTGCTGT ctca EPO
apoint mutation A to T at site indicated by double underline
Competition experiments show that HIF-1 binds less efficiently to the unique ET-1 and Flt-1
HBSs than to a prototypical HBS
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To investigate the HIF-binding properties of the HBS-containing oligonucleotides derived from the reported
ET-1 and Flt-1 HREs (Table 1C), we analysed nuclear extracts from normoxic or hypoxic human HeLa cells
by EMSA (Fig. 2). First, we demonstrated hypoxic induction of HIF-1 DNA-binding activity in these
extracts using oligonucleotide probes derived from the transferrin (Tf) HRE that contains two adjacent
HBSs shown previously to bind HIF-1 [55]. Homologous competition for DNA-binding by adding
increasing molar excesses of unlabelled Tf oligonucleotides demonstrated the specificity of HIF-1 binding
to the Tf probe. Heterologous competition with unlabelled ET-1 wild-type (wt) oligonucleotides also
decreased the intensity of the HIF-1 bands, but to a lesser extent than the homologous Tf competitor
oligonucleotides. The addition of Flt-1wt competitor oligonucleotides resulted in an even slighter decrease
of HIF-1 DNA-binding activity. These results indicate that the DNA-protein interaction activity of HIF-1
with the ET-1 and Flt-1 competitors is reduced compared with the Tf oligonucleotide probe. This might be
explained by two potential mechanisms: (1) HIF-2, which is also present in the nuclear extracts, might bind
the ET-1 and Flt-1 competitor oligonucleotides preferentially, thereby removing them from the available
competitor pool. This would increase the concentration of these oligonucleotides required to compete
efficiently for HIF-1 binding. (2) The unique ET-1 and Flt-1 competitor oligonucleotides might have a
decreased affinity for HIF-1, which would then bind the Tf oligonucleotide probe preferentially, and HIF-2
DNA binding activity is not involved in these competition experiments at all. It could not be established
whether HIF-1 or HIF-2 bound to the unique ET-1 and Flt-1 competitor oligonucleotides. 
Fig. 2. Homologous and heterologous DNA-binding competition experiments. Nuclear extracts derived
from HeLa cells were exposed to normoxic (-; 20% O2) or hypoxic (+; 1% O2) conditions for 4 h, and
electrophoretic mobility shift assay (EMSA) performed using increasing molar excesses of unlabelled
oligonucleotides as indicated (Tf transferrin, ET-1wt wild-type endothelin-1, Flt-1wt wild-type fms-like
tyrosine kinase, ATF-1/CREB-1 activating transcription factor-1/cAMP-responsive element-binding
protein-1)
In vitro-translated HIF-1 and HIF-2 both bind to the unique ET-1 HBS, but less efficiently
than to the EPO HBS
We next aimed to establish whether HIF-1 or HIF-2 bound preferentially to the reported ET-1 and Flt-1
HBSs. Because nuclear extracts from most cultured cell lines usually contain both HIF-1 and HIF-2 (see
above), we translated HIF-1 , HIF-2  and ARNT in vitro in separate reactions and subsequently allowed
the corresponding subunits to heterodimerize. Following addition of the respective oligonucleotide probe,
the reaction mixtures were analysed by EMSA (Fig. 3). Using in vitro-translated HIFs, both HIF-1 and
HIF-2 bound to an EPO control HBS with comparable efficiency. The presence of HIF-1  and HIF-2  was
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demonstrated by supershift experiments using specific antibodies that do not cross-react with any of the
other two known -subunits [4, 63, 75]. Equal protein addition to the EMSA reactions was verified by in
vitro translation in the presence of 35
DNA-binding activity could be observed when either of these three HIF subunits was analysed alone (data
not shown). 
Fig. 3. HIF-1 and HIF-2 binding to the reported ET-1 and Flt-1 HIF-binding segments (HBSs).
DNA-binding activity was assessed by EMSA using the oligonucleotide probes described in Table 1C and
in vitro-synthesized HIF-1 , HIF-2
DNA-binding protein complex was performed using mouse anti-HIF-1  (mgc3) and anti-HIF-2  (190b)
monoclonal antibodies (EPO erythropoietin)
The HIF-1 and HIF-2 DNA interaction with the ET-1wt probe was clearly reduced compared with that with
the EPO probe, demonstrated by the fact that much longer exposure times were necessary to detect the
ET-1wt bands. Interestingly, the relative DNA binding activity of in vitro-translated HIF-1 and HIF-2 was
comparable between the EPO and the ET-1 probes, indicating that the unusual HBS sequence did not confer
any preferential binding of HIF-1 or HIF-2, but rather attenuated overall DNA binding efficiency. To
analyse the impact of the 5 -adenosine residue on HIF-1 and HIF-2 DNA binding, we "back-mutated" this
residue to the more common thymidine (Table 1C). As shown in Fig. 3, this mutation of the ET-1T probe
restored both HIF-1 and HIF-2 DNA-binding efficiency fully, resulting in signal intensities similar to those
obtained with the EPO probe. These results suggest that the unique HBS in the ET-1 HRE lowers HIF DNA
binding activity rather than conferring specificity for either HIF.
Of note, neither Flt-1wt nor the back-mutated Flt-1T oligonucleotides bound in vitro-translated HIF-1 or
HIF-2, suggesting that the reported Flt-1 HRE apparently does not contain a functional HBS.
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DNA interaction of HIF-1 with the ET-1 HRE is attenuated compared with that with the EPO
HRE
HeLa and endothelial EAhy926 cells were exposed to hypoxia and nuclear extracts analysed by EMSA
(Fig. 4A and B, respectively). Using an oligonucleotide probe derived from the EPO 3 -HRE, HIF
DNA-binding activity was observed as well as a constitutive factor, shown previously to comprise activating
transcription factor-1 (ATF-1) and cAMP-responsive element-binding protein-1 (CREB-1) family members
[35]. Addition of the HIF-1 -specific monoclonal antibody mgc3 [4] resulted in a complete supershift of
the HIF band, identifying HIF-1 as the major hypoxia-induced DNA-binding protein complex binding the
EPO probe. 
Fig. 4. Restoration of DNA-binding by adenosine-to-thymidine mutation of the ET-1 HBS. EMSAs were
1C and nuclear extracts derived from HeLa
(A) or EAhy926 (B) cells. For supershift experiments anti-HIF-1  (mgc3) and anti-HIF-2  (190b)
monoclonal antibodies were used
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Similarly, completely supershifted HIF-1 DNA-binding activity was also observed using the ET-1wt probe,
suggesting that HIF-1, rather than HIF-2 or HIF-3, represents the major factor binding to ET-1 HRE in these
cell lines. The intensities of the ET-1wt bandshifts were reduced strongly compared with the EPO probe,
indicating decreased DNA-protein interactions of HIF-1 and ATF-1/CREB-1 with the ET-1 probe. As with
the in vitro-translated HIF proteins, adenosine-to-thymidine back-mutation fully restored HIF-1 and
ATF-1/CREB-1 DNA-binding activity to the level obtained with the EPO probe. Supershift experiments
using an anti-HIF-2  antibody confirmed that the HRE in the ET-1 gene was bound by HIF-1 rather than
HIF-2 (Fig. 4).
Again, no supershiftable HIF-1 DNA-binding activity was observed using the Flt-1wt probe. Instead, only a
non-specific band migrating in the gel between the induced and the supershifted HIF-1 DNA-binding
activity was detected. The adenosine-to-thymidine back-mutation did not restore HIF-1 DNA-binding
activity, but increased ATF-1/CREB-1 DNA-binding activity (Fig. 4). Non-specific DNA binding activity
was observed with all oligonucleotide probes used. The similar band intensities of this non-specific activity
ruled out the possibility that differences in the HIF-1 and ATF-1/CREB-1 DNA-binding activities were due
to differences in oligonucleotide probe labelling or DNA-protein binding reaction efficiencies.
Decreased cis-activation of reporter gene expression by the unique ET-1 HBS compared
with the EPO HBS
To analyse the functional implications of the observed differences in DNA-binding activities, we
constructed a series of luciferase reporter plasmids containing a heterologous simian virus-40 (SV40)
promoter and three or four copies of the 18-bp oligonucleotides EPO, ET-1wt, ET-1T, Flt-1wt or Flt-1T
(Table 1C) inserted downstream from the luciferase gene (Fig. 5A). HeLa and EAhy926 cells were
transfected transiently and incubated under normoxic or hypoxic conditions or in the presence of the
HIF-inducing iron chelator desferrioxamine (DFO). To correct the resulting luciferase expression levels for
differences in transfection efficiencies, the cells were co-transfected with a -galactosidase expression
vector. Following normalization with respect to the 
fold induction compared with normoxic controls (Fig. 5B). Three copies of the EPO oligonucleotide
conferred two- to fourfold induction of luciferase expression following hypoxic or DFO treatment of the
cells. In contrast, hypoxia resulted only in a very moderate increase in luciferase expression in HeLa cells
transfected with a plasmid containing three copies of the ET-1wt oligonucleotide. However, both cell lines
showed a strong induction of luciferase activity after transfection with reporter plasmids containing three
copies of the back-mutated ET-1T oligonucleotide. This functionally confirms our findings that hypoxic
regulation of ET-1 is attenuated by the critical 5
the more common thymidine residue. 
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Fig. 5. Reporter gene assays. A The oligonucleotides EPO, ET-1wt, ET-1T, Flt-1wt and Flt-1T (Table 1C)
were subcloned 3  of the luciferase reporter gene driven by the heterologous simian virus-40 (SV40)
promoter. Copy number (boxes) and orientation (arrows) are indicated. B, C Reporter gene expression in
transiently transfected HeLa (B) and EAhy926 (C) cells under normoxic (20% O2) or hypoxic (1% O2)
conditions or in the presence of the HIF-inducing agent desferrioxamine (DFO, 100 µM). Mean±SD fold
induction vs. untreated normoxic controls; n=3-6 independent experiments
As expected from the EMSA data (see above), both reporter constructs harbouring either the Flt-1wt or the
Flt-1T HBS oligonucleotides were unable to induce luciferase activity, suggesting that this HBS is
apparently not sufficient to confer hypoxic induction to the reported Flt-1 HRE.
12 von 19 29.08.01 17:44
DOI 10.1007/s004240100679
Discussion
HIF-1 and HIF-2 bind the same HBS and show a partially overlapping expression pattern in vivo. As in
other recent reports [23, 75], we showed that the two HIFs are also co-expressed in endothelial cells and
diverse cell lines in vitro. However, while both HIF-1 and HIF-2 showed DNA-binding activity following in
vitro translation, only HIF-1 DNA-binding activity could be detected in nuclear extracts. Intriguingly, while
reports of HIF-2 DNA-binding assays with recombinant proteins have been published [10, 65], no reports on
HIF-2 DNA-binding activity in nuclear extracts are available to date. This might be due to a lower nuclear
concentration of HIF-2 compared with HIF-1 or, alternatively, cell type-specific inhibitory factors of HIF-2
but not HIF-1 DNA-binding activity might be present in nuclear extracts but not in recombinant protein
products. Specific interference by such factors with HIF-2 DNA-binding activity might provide one
possibility for distinguishing functionally between these two closely related HIFs.
It remains, however, unclear whether, and if so, how, the two HIFs distinguish between particular target
genes. Here, we demonstrated that the two endothelium-specific HIF target genes ET-1 and Flt-1 contained
an unusual adenosine residue 5  to the core HBS consensus sequence. This finding provides a possible
answer to the question, but the unusual ET-1/Flt-1 HBS did not mediate any significant binding preferences
of HIF-1 or HIF-2. Rather, it attenuated both DNA-binding and transcriptional activation by the HIFs in the
case of the ET-1 HBS, and even abolished these functions in the case of the Flt-1 HBS.
The Flt-1 HRE has been identified as a 40-bp fragment, located 959 bp upstream from the transcriptional
start site, which is sufficient to mediate the anoxic induction of a heterologous reporter gene in Hep3B and
HeLa non-ECs [19]. Of note, neither HRE function in hypoxic ECs nor HIF-1 binding to a putative HBS
within this HRE have been demonstrated [19
reporter gene and EMSA studies is unlikely to explain the lack of activity, because similar probes and
constructs derived from the EPO and ET-1 genes functioned satisfactorily in our assays. Even chelation of
iron (mimicking anoxic conditions) did not result in the functional activation of reporter genes containing
three Flt-1 HBSs, suggesting that the degree of hypoxia is not related to the degree of HIF-dependent Flt-1
gene activation. However, severe hypoxia still might activate stress-inducible factors that confer activation
of the longer Flt-1 HRE via HBS-independent cis-regulatory mechanisms.
Results concerning hypoxic up-regulation of VEGFRs are inconsistent. Systemic hypoxia up-regulates
VEGFR1 but not VEGFR2 in mice [43
VEGFR2 are induced under hypoxic conditions [67]. In addition, hypoxic VEGFR up-regulation is also
mediated by paracrine factors including VEGF itself [1, 60, 68]. Thus, it is conceivable that hypoxic
activation of the reported Flt-1 HRE requires factors in addition to HIF-1 or HIF-2 and/or that an additional
HRE containing a functional, not yet identified, HBS might exist. Non-functional putative HBSs, despite a
perfect match to the core consensus sequence, have been identified previously in the genes encoding
glycolytic enzymes [58, 59] as well as HIF-1  itself [73].
The HBS within the HRE of the ET-1 gene is critical for hypoxic induction. Whereas the GATA-binding
transcription factor-2 (GATA-2) and activator protein-1 (AP-1) elements are essential for high-level
expression of ET-1, only the HBS mutation abolished the hypoxic response [36, 37]. Indeed, ET-1 HBS is
not sufficient for efficient hypoxic induction, but requires the additional DNA-binding elements for the
AP-1 and GATA-2 transcription factors in the vicinity of the HBS [77]. Our data confirm this and suggest
that HBSs containing the unusual 5 -flanking adenosine residue not only attenuate the hypoxic response but
also allow this response to be triggered via other signalling pathways that culminate in the regulation of the
HRE activity.
The extent of hypoxic ET-1 mRNA induction in vivo is rather low, e.g. threefold induction by hypoxia and
1.75-fold induction by CoCl2 in human microvascular endothelial cells [46]. In rats exposed to 8% O2,
anaemia (0.1% CO), haemorrhage or CoCl2, analysis of EPO and ET-1 mRNA expression showed
comparable basal EPO and ET-1 mRNA expression levels in liver and kidney [54]. Interestingly, while
hypoxia and anaemia increased EPO mRNA up to 150-fold in the kidney and 20-fold in the liver, ET-1
mRNA levels increased maximally fourfold under the same conditions. As shown in the present study,
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back-mutation of the wild-type ET-1 HBS to a EPO-like HBS restored DNA-binding and transcriptional
activity to the same levels as those of the EPO HBS. This is evidence that the unusual ET-1 HBS serves to
attenuate the hypoxic response of this very potent vasoconstrictor, thereby possibly limiting the extent of
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